Clinical trial
Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are…
NCT00238147 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00238147 |
|---|---|
| Title | Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer |
| Official title | Phase I Trial With Weekly Docetaxel, Capecitabine and Carboplatin as Induction Chemotherapy Followed by Concomitant Capecitabine and Radiotherapy in Patients With Locally Advanced Esophageal Cancer |
| Lead sponsor | University of Washington, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, carboplatin, docetaxel, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 18 |
| Start date | Sep 1, 2004 |
| Completion | Aug 1, 2008 |
| First posted | Oct 13, 2005 |
| Last update posted | May 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: